We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Elevated Metabolites Signal Diabetes Risk

By LabMedica International staff writers
Posted on 06 Apr 2011
Increased levels of amino acids in the blood can identify individuals at risk of developing diabetes mellitus type 2. More...


Amino acids, amines and other polar metabolites can be profiled in baseline blood specimens by liquid chromatography–tandem mass spectrometry (LC-MS), and correlated with disease progression.

A team led by scientists at Massachusetts General Hospital (MGH; Boston, MA, USA) recently found that the levels of five amino acids, identified by LC-MS, indicated increased diabetes risk in a general population. Out of 2,400 normoglycemic participants who entered the study in 1991 and 1995, 201 developed type 2 diabetes during the subsequent 12 years. Using the baseline blood samples, the research team measured levels of 61 metabolites in 189 participants who later developed diabetes and 189 diabetes free individuals, who were matched for age, sex, and diabetes risk factors.

The analysis found that elevations in five amino acids: isoleucine, leucine, valine, tyrosine, and phenylalanine, were significantly associated with the later development of type 2 diabetes and could also differentiate, among individuals with traditional risk factors such as obesity, and those most likely to actually develop diabetes. The investigators found that measuring combinations of several metabolites, as opposed to a single amino acid, improved risk prediction. Overall, in individuals closely matched for traditional risk factors for type 2 diabetes, those with the highest levels of the three most predictive amino acids had a four to five times greater risk of developing diabetes than did those with the lowest levels. These findings underscore the potential key role of amino acid metabolism early in the pathogenesis of diabetes and suggest that amino acid profiles could aid in diabetes risk assessment.

Thomas J. Wang, MD, the lead author of the study, said, "These findings could provide insight into metabolic pathways that are altered very early in the process leading to diabetes. They also raise the possibility that, in selected individuals, these measurements could identify those at highest risk of developing diabetes so that early preventive measures could be instituted." The study was published online on March 20, 2011, in Nature Medicine.

Related Links:

Massachusetts General Hospital



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Pipette Calibration System
Artel PCS®
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.